Flow Cytometry
Flow Cytometry
批准号:
10617298
负责人:
Michael Birnbaum
金额:
$23.25万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-06-17 至 2025-04-30
关键词:
AntibodiesApoptosisBioinformaticsBudgetsCancer Center Support GrantCell Cycle ProgressionCell SeparationCell surfaceCellsCollaborationsConsultationsCytometryDNA DamageData AnalysesDetectionDevelopmentEducationEducational workshopEngineeringEvaluationExperimental DesignsFlow CytometryFluorescence-Activated Cell SortingFundingGenomicsImaging technologyIndividualInformation CentersLabelLasersMethodsMissionMultiplexed Ion Beam ImagingPhenotypePopulationProteinsProtocols documentationRecoveryReporter GenesResearchResearch PersonnelResearch SupportResource SharingResourcesRoboticsSamplingServicesSourceSpecialistSpeedSystemTechnical ExpertiseTechniquesTechnologyTherapeuticTraininganticancer researchcopolymerdata acquisitionfluorophoreinstrumentinstrumentationinterestmemberoperationprogramsresponsesingle cell analysissingle cell mRNA sequencingsingle-cell RNA sequencingsuccesstraining opportunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Flow Cytometry Core: Project Summary/Abstract
Flow cytometry is an essential method in cancer research. It is widely used to identify, track and purify specific
cell populations through analysis of cell surface markers and/or fluorescent reporter genes, and also to assess
cellular phenotypes, such as cell cycle progression, DNA damage or apoptosis responses. Flow cytometry also
supports a broad range of engineering-based approaches, such as quantification of targeting efficiencies for
antibody- and copolymer-based therapeutic delivery systems, and high-throughput approaches to develop
fluorophore-based protein labeling and imaging technology. The Koch Institute Flow Cytometry Core is a
Shared Resource that provides Center Members with training in, and access to, state-of-the-art cell sorting
instrumentation, technical expertise and training, and data analyses.
In the current period, the capabilities of this Core were further expanded and enhanced. Two new analyzers
and two new sorters were acquired, replacing older obsolete instrumentation, and three systems were
upgraded with new lasers to expand detection capabilities. Core service usage by Center Member has
remained high (93% of Center Members). In addition, using CCSG Developmental Funds, the Core has
supported a Research Specialist who has established a suite of single cell-associated technologies, including a
collaboration with the Koch Institute Integrated Genomics & Bioinformatics Core to enable high throughput
single cell mRNA sequencing. These services are now well-developed services within the Core, and we seek
continued, partial funding to support the Research Specialist’s efforts.
In the upcoming period, the Flow Cytometry Core will continue to offer a wide range of state-of-the-art services
to support the research programs of Center Members and will evaluate emerging capabilities in the context of
Center Member needs and interests. The Core intends to evaluate high parameter cell sorting, addition of
robotics capabilities for automated sampling, mass cytometry, and multiplexed ion beam imaging. The Core
will also expand training opportunities, including hands-on data analysis workshops. This Shared Resource is
essential to the success of the Koch Institute mission and provides exceptional value to the CCSG because
Koch Institute Members account for 84% of the Core services usage. The requested CCSG budget for Year 49
is increased by 9.2% over the budget in the current period (Year 48), reflecting the request for additional
funding to stabilize support for the new single cell analysis capabilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
-
批准号:10436483
-
项目类别:
-
资助金额:$72.85万
-
财政年份:2022
-
负责人:Michael Birnbaum
-
依托单位:
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
-
批准号:10621960
-
项目类别:
-
资助金额:$67.46万
-
财政年份:2022
-
负责人:Michael Birnbaum
-
依托单位:
Development of an emulsion-based method for repertoire-scale paired-chain T cell receptor sequencing
-
批准号:10371136
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2021
-
负责人:Michael Birnbaum
-
依托单位:
Repertoire-scale T cell antigen identification via peptide-MHC lentivirus display
-
批准号:10001123
-
项目类别:
-
资助金额:$231.64万
-
财政年份:2020
-
负责人:Michael Birnbaum
-
依托单位:
Determining antigen recognition in systemic sclerosis
-
批准号:10188400
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2014
-
负责人:Michael Birnbaum
-
依托单位:
Determining antigen recognition in systemic sclerosis
-
批准号:9915867
-
项目类别:
-
资助金额:$11.3万
-
财政年份:--
-
负责人:Michael Birnbaum
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: